-

Global Vulnerability Management Growth Opportunities/Analysis Report 2023: Enhancing Vulnerability Risk Scores - Contextual Prioritization for Accurate Assessments - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Vulnerability Management Growth Opportunities" report has been added to ResearchAndMarkets.com's offering.

Customer Demand for Accuracy, Scalability, and Automation Accelerating Technology Transformation

This study classifies 3 different VM product types - vulnerability assessment, vulnerability prioritization and remediation, and VM-as-a-service - focusing on market size, trends, and the global growth outlook.

Vulnerabilities are errors or weaknesses in a software program, network, application, or endpoint that enable an unauthorized user to access sensitive data, gain control, or deny access to authorized users. At a high level, the publisher defines VM as a platform that offers vulnerability assessments and provides assessment results that can trigger an appropriate remediation response.

VM has evolved since its late 1990s origins in network scanning. Initially, network scanners probed servers for vulnerabilities and identified vulnerable endpoints. Today, scan technology has expanded to survey all network-attached endpoints, cloud-based applications, servers, and connected devices.

Growth Opportunities

  • Leverage Growing Demand in Emerging Economies
  • Leverage Growing Demand in SMEs for VM Tools
  • Incorporate Contextual Prioritization and Improve Accuracy of Vulnerability Risk Scores
  • Leverage MSSPs as a Revenue Source to Expand the Customer Base

Key Topics Covered:

1. Strategic Imperatives

  • Why is it Increasingly Difficult to Grow?
  • The Strategic Imperative
  • The Impact of the Top 3 Strategic Imperatives on the Global Vulnerability Management (VM) Market
  • Growth Opportunities Fuel the Growth Pipeline Engine

2. Growth Opportunity Analysis

  • Scope of Analysis
  • Segmentation
  • Key Competitors
  • Growth Metrics
  • Distribution Channels
  • Growth Drivers
  • Growth Drivers Analysis
  • Growth Restraints
  • Growth Restraints Analysis
  • Forecast Assumptions
  • Revenue Forecast
  • Revenue Forecast by Product
  • Revenue Forecast by Region
  • Revenue Forecast by Business Size
  • Revenue Forecast Analysis
  • Pricing Trends and Forecast Analysis
  • Competitive Environment
  • Revenue Share
  • Revenue Share Gain/Loss
  • Revenue Share Analysis

3. Growth Opportunity Analysis: Vulnerability Assessment

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Region
  • Forecast Analysis

4. Growth Opportunity Analysis: Vulnerability Prioritization and Remediation

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Region
  • Forecast Analysis

5. Growth Opportunity Analysis: Vulnerability Management-as-a-Service

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Region
  • Forecast Analysis

6. Insights for CISOs

  • Top 10 Must-have Capabilities in VM Tools
  • Licensing Options
  • Buying Guide - Asset Coverage/Visibility
  • Manual vs Automated VM program

For more information about this report visit https://www.researchandmarkets.com/r/so1hn0

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Sysmex Corp (6869) Product Pipeline Analysis Report 2025: Haematology, Haemostasis, and Urinalysis Analyzers - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Sysmex Corp (6869) - Product Pipeline Analysis, 2025 Update" company profile has been added to ResearchAndMarkets.com's offering. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. Sysmex Corp (Sysmex) is a provider of medical devices that researches, develops, manufactures and sells instruments, reagents, and s...

Ypsomed Holding AG (YPSN) Product Pipeline Analysis Report 2025: Self-Injection and Infusion Systems Portfolio - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Ypsomed Holding AG (YPSN) - Product Pipeline Analysis, 2025 Update" company profile has been added to ResearchAndMarkets.com's offering. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. Ypsomed Holding AG (Ypsomed) is a medical device company. It designs, develops, and manufactures injection and infusion syste...

Cochlear Ltd (COH) Product Pipeline Analysis Report 2025: Portfolio Includes Cochlear Implants, Bone Conduction Systems, Acoustic Implants, and Wireless Accessories - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Cochlear Ltd (COH) - Product Pipeline Analysis, 2025 Update" company profile has been added to ResearchAndMarkets.com's offering. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. Cochlear Ltd (Cochlear) is a medical device company that offers implantable hearing solutions to customers. It develops, manufacture...
Back to Newsroom